FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. H.
Right arrow Articles by Zemel, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. H.
Right arrow Articles by Zemel, M. B.

The FASEB Journal, Vol 10, 1646-1652, Copyright © 1996 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

The effects of calcium channel blockade on agouti-induced obesity

JH Kim, RL Mynatt, JW Moore, RP Woychik, N Moustaid and MB Zemel
Department of Nutrition, University of Tennessee, Knoxville 37996, USA.

We have previously observed that obese viable yellow (Avy/a) mice exhibit increased intracellular Ca2+ ([Ca2+]i) and fatty acid synthase (FAS) gene expression; further, recombinant agouti protein increases in cultured adipocytes and these effects are inhibited by Ca2+ channel blockade. Accordingly, we determined the effect of Ca2+ channel blockade (nifedipine for 4 wk) on FAS and obesity in transgenic mice expressing the agouti gene in a ubiquitous manner. The transgenic mice initially were significantly heavier (30.5+/-0.6 vs. 27.3+/-0.3 g; P<0.001) and exhibited a 0.81 degrees C lower initial core temperature (P<0.0005), an approximately twofold increase in fat pad weights (P=0.002), a sevenfold increase in adipose FAS activity (P=0.009), and a twofold increase in plasma insulin level (P<0.05) compared to control mice. Nifedipine treatment resulted in an 18% decrease in fat pad weights (P<0.007) and a 74% decrease in adipose FAS activity (P=0.03), normalized circulating insulin levels and insulin sensitivity (P<0.05), and transiently elevated core temperature in the transgenic mice, but was without effect in the control mice. These data suggest that agouti regulates FAS, fat storage, and possibly thermogenesis, at least partially, via a [Ca2+]i-dependent mechanism, and that Ca2+ channel blockade may partially attenuate agouti-induced obesity.


This article has been cited by other articles:


Home page
 J. Am. Coll. Nutr.Home page
M. B. Zemel
The Role of Dairy Foods in Weight Management
J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 537S - 546S.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. F. Evans, C.-L Shen, S. Pollack, J. F. Aloia, and J. K. Yeh
Adrenocorticotropin Evokes Transient Elevations in Intracellular Free Calcium ([Ca2+]i) and Increases Basal [Ca2+]i in Resting Chondrocytes through a Phospholipase C-Dependent Mechanism
Endocrinology, July 1, 2005; 146(7): 3123 - 3132.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
X. Sun and M. B. Zemel
Calcium and Dairy Products Inhibit Weight and Fat Regain during Ad Libitum Consumption Following Energy Restriction in Ap2-Agouti Transgenic Mice
J. Nutr., November 1, 2004; 134(11): 3054 - 3060.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. B Zemel
Role of calcium and dairy products in energy partitioning and weight management
Am. J. Clinical Nutrition, May 1, 2004; 79(5): 907S - 912S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. Jacqmain, E. Doucet, J.-P. Despres, C. Bouchard, and A. Tremblay
Calcium intake, body composition, and lipoprotein-lipid concentrations in adults
Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1448 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. B. Zemel
Mechanisms of Dairy Modulation of Adiposity
J. Nutr., January 1, 2003; 133(1): 252S - 256.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
M. B. Zemel
Regulation of Adiposity and Obesity Risk By Dietary Calcium: Mechanisms and Implications
J. Am. Coll. Nutr., April 1, 2002; 21(2): 146S - 151.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
M. B. Zemel
Calcium Modulation of Hypertension and Obesity: Mechanisms and Implications
J. Am. Coll. Nutr., October 1, 2001; 20(90005): 428S - 435.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
S. Kim and N. Moustaid-Moussa
Secretory, Endocrine and Autocrine/Paracrine Function of the Adipocyte
J. Nutr., December 1, 2000; 130 (12): 3110S - 3115S.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Ste. Marie, G. I. Miura, D. J. Marsh, K. Yagaloff, and R. D. Palmiter
A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors
PNAS, October 4, 2000; (2000) 220409497.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
B. Xue and M. B. Zemel
Relationship between Human Adipose Tissue Agouti and Fatty Acid Synthase (FAS)
J. Nutr., October 1, 2000; 130(10): 2478 - 2481.
[Abstract] [Full Text]

Home page
 Physiol. GenomicsHome page
K. J. CLAYCOMBE, Y. WANG, B. H. JONES, S. KIM, W. O. WILKISON, M. B. ZEMEL, J. CHUN, and N. MOUSTAID-MOUSSA
Transcriptional regulation of the adipocyte fatty acid synthase gene by agouti: interaction with insulin
Physiol Genomics, September 8, 2000; 3(3): 157 - 162.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. B. ZEMEL, H. SHI, B. GREER, D. DIRIENZO, and P. C. ZEMEL
Regulation of adiposity by dietary calcium
FASEB J, June 1, 2000; 14(9): 1132 - 1138.
[Abstract] [Full Text]

Home page
 FASEB J.Home page
M. STANDRIDGE, R. ALEMZADEH, M. ZEMEL, J. KOONTZ, and N. MOUSTAID-MOUSSA
Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats
FASEB J, March 1, 2000; 14(3): 455 - 460.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M. M. Ollmann and G. S. Barsh
Down-regulation of Melanocortin Receptor Signaling Mediated by the Amino Terminus of Agouti Protein in Xenopus Melanophores
J. Biol. Chem., May 28, 1999; 274(22): 15837 - 15846.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
B. Xue, N. Moustaid-moussa, W. O. Wilkison, and M. B. Zemel
The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism
FASEB J, October 1, 1998; 12(13): 1391 - 1396.
[Abstract] [Full Text]

Home page
 Genes Dev.Home page
M. M. Ollmann, M. L. Lamoreux, B. D. Wilson, and G. S. Barsh
Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo
Genes & Dev., February 1, 1998; 12(3): 316 - 330.
[Abstract] [Full Text]

Home page
 ScienceHome page
M. M. Ollmann, B. D. Wilson, Y. Yang, J. A. Kerns, Y. Chen, I. Gantz, and G. S. Barsh
Antagonism of Central Melanocortin Receptors in Vitro and in Vivo by Agouti-Related Protein
Science, October 3, 1997; 278(5335): 135 - 138.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
R. J. Miltenberger, R. L. Mynatt, J. E. Wilkinson, and R. P. Woychik
The Role of the agouti Gene in the Yellow Obese Syndrome
J. Nutr., September 1, 1997; 127(9): 1902 - 1902.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Ste. Marie, G. I. Miura, D. J. Marsh, K. Yagaloff, and R. D. Palmiter
A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors
PNAS, October 24, 2000; 97(22): 12339 - 12344.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
B. Z. XUE, W. O. WILKISON, R. L. MYNATT, N. MOUSTAID, M. GOLDMAN, and M. B. ZEMEL
The agouti gene product stimulates pancreatic {beta}-cell Ca2+ signaling and insulin release
Physiol Genomics, July 15, 1999; 1(1): 11 - 19.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by The Federation of American Societies for Experimental Biology.